Our mission
to save human lives by early detection of heart injury
to save human lives by early detection of heart injury
Over 10 million visits to emergency departments (EDs) for chest pain each year.
Only 1 out of 5 are cardiac causes.
In order to rule out the rest, a series of cardiac protein measurements that each take ~55 minutes, result in hours of unnecessary hospitalization for patients with non-cardiac causes.
Non-invasive, instant measurement of cardiac proteins that improve patient outcomes, while reducing hospital length of stay and associated healthcare cost burdens.
The editorial discusses the content of eight abstracts from the "17th Annual Biomarkers and Personalised Medicine in Cardiovascular Disease Symposium," published in Biomarkers. These abstracts touch on various aspects of cardiovascular biomarkers, including markers for cardiac injury, infarction, arrhythmias, acute heart failure, and infection.
Carlsbad, CA (August 10, 2023) - RCE Technologies, Inc. In the dynamic world of medical research, the quest for accurate diagnostics remains an ever-evolving endeavor. Dr. Frank Peacock, a distinguished figure in the medical community, shared his insights on groundbreaking projects during a recent
Carlsbad, CA (July 11, 2023) - RCE.ai, an innovative health tech company, has been chosen as one of the new participants in the prestigious Cedars-Sinai Accelerator program. This selection recognizes RCE.ai's groundbreaking advancements in healthcare technology and its potential to transform patient
